A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours

• Main Authors: Ang, Y.L.E., Ho, G.F., Soo, R.A., Sundar, R., Tan, S.H., Yong, W.P., Ow, S.G.W., Lim, J.S.J., Chong, W.Q., Soe, P.P., Tai, B.C., Wang, L., Goh, B.C., Lee, S.-C.
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Published: BioMed Central Ltd 2021
• Subjects: Advanced solid tumours; Anti-angiogenic; Docetaxel; Short-course sunitinib; Tumour vasculature
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/199287
• Institution: National University of Singapore

10.1186/s12885-020-07616-4